idarubicin has been researched along with Liver Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, H; Aho, LS; Bedenne, L; Boulin, M; Cercueil, JP; Di Martino, C; Fagnoni, P; Guiu, B; Hillon, P; Jouve, JL; Lepage, C; Minello, A | 1 |
1 other study(ies) available for idarubicin and Liver Cirrhosis
Article | Year |
---|---|
Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Chemoembolization, Therapeutic; Cohort Studies; Doxorubicin; Female; Hepatic Encephalopathy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Idarubicin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Burden | 2014 |